Phase 1 study in Staphylococcus aureus endocarditis
Phase 1
Recruiting
- Conditions
- Infectious S. aureus endocarditisMedDRA version: 20.1Level: LLTClassification code: 10041937Term: Staphylococcus aureus endocarditis Class: 10021881Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- CTIS2023-505413-25-00
- Lead Sponsor
- Phaxiam Therapeutics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method